FDA Approves Rare Pediatric Disease Designation for IMX-110 for Rhabdomyosarcoma
- OPACC
- Jan 19, 2022
- 1 min read
Officials with the FDA have approved a Rare Pediatric Disease Designation for IMX-110 for the treatment of pediatric patients with rhabdomyosarcoma.
Comments